Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research gets to heart of advertising gender bias

09.12.2004


Women not very visible in ads for cardio drugs



Gender bias in pharmaceutical advertisements for cardiovascular disease may affect treatment, says a new University of Toronto study. After examining 919 cardiovascular drug ads displayed in American medical and cardiovascular journals published between January 1996 and June 1998, U of T’s Dr. Angela Cheung and her colleagues concluded that 80 per cent depicted male patients and the remaining 20 per cent featured women. They are concerned that the gender inequity seen in the ads may contribute to known disparities in how physicians treat men and women with similar heart problems.

"Studies have shown that women are referred later and less frequently for cardiac catheterization and for coronary artery bypass surgery," says Cheung, a professor in U of T’s Department of Medicine and associate director of the Women’s Health Program at the University Health Network’s Toronto General Hospital. "There are also gender-based differences in the use of aspirin, beta-blockers and thrombolytic therapies.


"The gender bias in advertising is a cause for concern, since there is evidence from other research that physicians use pharmaceutical advertisements as an important source of medical information."

The study also determined that the age and race of patients in ads differed according to gender. The women were portrayed as younger than the men, despite the fact that heart disease affects women later in life than men. There were also few non-whites shown in the ads – the typical patient depicted was a middle-aged white male. The authors note that physicians routinely underestimate the prevalence and severity of heart disease among women and express concern that their findings also mirror the medical literature.

"While efforts to increase female representation in cardiovascular trials are ongoing, the vast majority of scientific evidence is based on men," says Cheung. This study appears in the November issue of the Journal of Evaluation in Clinical Practice.

Elaine Smith | EurekAlert!
Further information:
http://www.utoronto.ca

More articles from Studies and Analyses:

nachricht Win-win strategies for climate and food security
02.10.2017 | International Institute for Applied Systems Analysis (IIASA)

nachricht The personality factor: How to foster the sharing of research data
06.09.2017 | ZBW – Leibniz-Informationszentrum Wirtschaft

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>